Sponsors

Russian Science Foundation, grant 15_14-30039 "Immunotherapy and immunoprophylaxis of drug resistance in chronic viral infections: examples of HIV-1 and HCV"

Project initiation grant of the Swedish institute "INNVOIMMUNE" 

Russian Fund for Basic Research grants 17_04_20526, 17-54-30002 and 17-04-00583 to the Gamalya Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, Russia;

BEX Ltd, Tokyo, Japan; http://www.bexnet.co.jp 

Attendance of participants from Riga Stradins University, Riga; Karolinska Institutet, Stockholm; Lodz University, Poland was supported by EU Horizon2020 project “Twinning on DNA-based cancer vaccines” Agreement Nr 692293.

Support is acknowledged from the Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products of Russian Academy of Sciences, Moscow, Russia; MI Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russia; Riga Stradins University, Riga, Latvia; Karolinska Institutet, Stockholm, Sweden.